Multiple sclerosis (MS) patients’ gut bacterial compositions differ significantly from those of healthy people, according to a global research team lead by UC San Francisco researchers, as do MS patients who are taking various pharmacological treatments. Intestinal bacteria have been linked in recent years to a variety of illnesses, not simply those affecting the gut, […]
Fabimycin demonstrated potential in the fight against more than 200 antibiotic-resistant microorganisms
The results of this study appear in ACS Central Science. Bacterial antimicrobial resistance (AMR) occurs when bacteria mutate over time and no longer respond to antibiotics, making infections more difficult to treat and increasing the risk of disease spread, severe illness, and death. Scientists have described infections due to antibiotic-resistant bacteria as a threat to modern […]
